4//SEC Filing
GREENLEAF DANIEL E 4
Accession 0001127602-19-015956
CIK 0001014739other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 1:33 PM ET
Size
13.3 KB
Accession
0001127602-19-015956
Insider Transaction Report
Form 4
BioScrip, Inc.BIOS
GREENLEAF DANIEL E
Chief Executive Officer
Transactions
- Disposition to Issuer
Common Stock, $.0001 Par Value
2019-04-18$1.82/sh−67,994$123,749→ 240,312 total - Exercise/Conversion
Restricted Stock Unit
2019-04-18−136,185→ 0 totalExp: 2019-12-31→ Common Stock, $.0001 Par Value (136,185 underlying) - Exercise/Conversion
Common Stock, $.0001 Par Value
2019-04-18+136,185→ 209,881 total - Exercise/Conversion
Common Stock, $.0001 Par Value
2019-04-18+98,425→ 308,306 total - Exercise/Conversion
Restricted Stock Unit
2019-04-18−98,425→ 196,850 total→ Common Stock, $.0001 Par Value (98,425 underlying)
Footnotes (7)
- [F1]136,185 Restricted Stock Units (RSUs) vested in January 2019 based on the satisfaction of certain Company stock price trading targets; however, as provided in the grant agreement, the Company deferred settlement of the 136,185 RSUs until April 18, 2019
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
- [F3]One third (98,425 RSUs) of Mr. Greenleaf's original award of 295,275 RSUs vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the 98,425 RSUs until April 18, 2019.
- [F4]This transaction represents shares withheld by the Company for tax withholding on Mr. Greenleaf's settlement of the two RSU awards described in this Form 4 that were settled on April 18, 2019.
- [F5]Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock. Vesting occurs if Company stock price, as measured by 20-day average stock price ending December 31, 2019, reaches specified levels.
- [F6]Depending on Company stock price at the end of the performance period, payout may be 0, 50, 100 or 200% of reported amount.
- [F7]The remaining 196,850 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018).
Documents
Issuer
BioScrip, Inc.
CIK 0001014739
Entity typeother
Related Parties
1- filerCIK 0001208492
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 1:33 PM ET
- Size
- 13.3 KB